Reviewer's report
Title:Prevalence and severity of antipsychotic related constipation in patients
with schizophrenia: a retrospective descriptive study.
Version: 2Date:7 February 2011
Reviewer: Takefumi Suzuki
Reviewer's report:
The reviewer thinks the authors have adequately addressed concerns raised by
the referees. In Table 1, brand name for q(Q)uetiapine is missing. Also,
"sedative" may appear as "Low-potency typicals". The reviewer has no further
comments.
Level of interest: An article of importance in its field
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
Dr. Suzuki has received fellowship grants from the Japanese Society of Clinical
Neuropsychopharmacology, Government of Canada Post-Doctoral Research
Fellowships, Kanae Foundation, and Mochida Memorial Foundation, and
manuscript fees from Kyowa Hakko Kirin and Dainippon Sumitomo Pharma.
Reviewer's report
Title:Prevalence and severity of antipsychotic related constipation in patients
with schizophrenia: a retrospective descriptive study.
Version: 2Date:7 February 2011
Reviewer: Takefumi Suzuki
Reviewer's report:
The reviewer thinks the authors have adequately addressed concerns raised by
the referees. In Table 1, brand name for q(Q)uetiapine is missing. Also,
"sedative" may appear as "Low-potency typicals". The reviewer has no further
comments.
Level of interest: An article of importance in its field
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
Dr. Suzuki has received fellowship grants from the Japanese Society of Clinical
Neuropsychopharmacology, Government of Canada Post-Doctoral Research
Fellowships, Kanae Foundation, and Mochida Memorial Foundation, and
manuscript fees from Kyowa Hakko Kirin and Dainippon Sumitomo Pharma.
Please review this paper.
user
Reviewer's report
Title:Prevalence and severity of antipsychotic related constipation in patients
with schizophrenia: a retrospective descriptive study.
Version: 2Date:7 February 2011
Reviewer: Takefumi Suzuki
Reviewer's report:
The reviewer thinks the authors have adequately addressed concerns raised by
the referees. In Table 1, brand name for q(Q)uetiapine is missing. Also,
"sedative" may appear as "Low-potency typicals". The reviewer has no further
comments.
Level of interest: An article of importance in its field
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a
statistician.
Declaration of competing interests:
Dr. Suzuki has received fellowship grants from the Japanese Society of Clinical
Neuropsychopharmacology, Government of Canada Post-Doctoral Research
Fellowships, Kanae Foundation, and Mochida Memorial Foundation, and
manuscript fees from Kyowa Hakko Kirin and Dainippon Sumitomo Pharma.
assistant